Rx Import Alert: CVS Branded Generic Drugs Singled Out In Bloomberg Report For Most Recalls Archive, China, commentary, Commentary Featured, CPA News, Featured Home Page, Healthcare, Manufacturing, Newsroom, Supply ChainBy Kenneth RapozaJune 13, 2024The foreign labs in China and India that make the branded drugs for CVS pharmacies nationwide are coming under increased scrutiny for unsafe manufacturing practices.
CPA Guest Opinion: We Must Revoke China’s Most Favored Nation Status Archive, China, Featured Home Page, Guest Opinion & Press Releases, Manufacturing, op-ed, Renewable Energy, Supply Chain, Technology, Trade and TariffsBy Guest AuthorJune 13, 2024It’s time for us to stop treating China as a friend and recognize China as the enemy to our national sovereignty that it is.
